Cynosure Group’s Elanco Animal Health ELAN Stock Holding History

Cynosure Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,670	Closed	-$423K	–	206
2026 Q1	$423K	Buy	+17,670	New	+$432K	0.05%	124

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Cynosure Group's ELAN Position: Q2 2026 in Review

Cynosure Group sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 17,670 shares — an estimated $423K sold.

Cynosure Group first reported a position in ELAN in Q1 2026 and held it in 1 quarter. The position peaked at $423K in Q1 2026. 521 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Cynosure Group reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
Cynosure Group sold 17,670 Elanco Animal Health shares in Q2 2026, an estimated $423K.
Cynosure Group first reported a position in Elanco Animal Health in Q1 2026 and held it in 1 quarter.
Cynosure Group's Elanco Animal Health position peaked at $423K in Q1 2026.
521 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.